EXEL

Exelixis, Inc. News Headlines

$2.93
*  
unch
unch
Get EXEL Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading EXEL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EXEL Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Roche Gets FDA Priority Review for Cancer Treatment
2/19/2015 2:02:00 AM - Dow Jones Business News


Exelixis: FDA Accepts For Review Genentech NDA For Cobimetinib With Vemurafenib
2/19/2015 1:18:00 AM - RTT News


Even With Recent Exelixis Price Action, Outlook Remains Unchanged
2/18/2015 9:12:00 AM - Seeking Alpha


Exelixis: Expected METEOR Trial Success Changes Everything
2/17/2015 10:54:00 AM - Seeking Alpha


4 Biotech Stocks Under $10 Triggering Breakouts: Amarin, Exelixis and More
2/10/2015 2:01:00 PM - TheStreet


Update: My Take On Exelixis' New Agreement With Sobi To Provide COMETRIQ In Europe
1/7/2015 11:50:00 AM - Seeking Alpha


Exelixis, Sobi Extend & Restructure Distribution Agreement For COMETRIQ
1/7/2015 9:08:00 AM - RTT News


Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog
12/17/2014 10:26:00 AM - Investopedia


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 AM - Investopedia


Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact
12/16/2014 1:24:00 AM - Seeking Alpha


Genentech Submits NDA For Cobimetinib With Zelboraf To Treat Advanced Melanoma
12/15/2014 1:27:00 AM - RTT News


Array BioPharma Advances To All Systems Go, Collects $85 Million
12/12/2014 9:13:00 AM - Seeking Alpha


Exelixis' COMET-2 Failure And A Discussion Of Potential Future Cash Flow
12/3/2014 3:51:00 PM - Seeking Alpha


Update: Exelixis Announces Final COMET-2 Data- What Can Shareholders Do?
12/1/2014 1:31:00 PM - Seeking Alpha


Exelixis: Why This Company Could Become The Next Dendreon
11/18/2014 12:54:00 PM - Seeking Alpha


Update: Exelixis Announces Very Positive Phase 1 Trial Data
11/18/2014 1:28:00 AM - Seeking Alpha


Biotech Weekly: Here Come The Institutional Holdings Updates
11/17/2014 8:31:00 AM - Seeking Alpha


Update: Exelixis Reports Q3 Earnings - Impact To My Thesis
11/7/2014 4:42:00 AM - Seeking Alpha


Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis
9/29/2014 9:57:00 AM - Seeking Alpha


Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick
9/16/2014 8:38:00 AM - Seeking Alpha


Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha


Update: Exelixis COMET-1 Trial Fails: The Impact To My Bull Thesis
9/2/2014 2:38:00 PM - Seeking Alpha


Can You Handle Risk? With A Dozen Clinical Trials, Exelixis Has Strong Upside Potential
8/19/2014 12:08:00 PM - Seeking Alpha


A Quick Look At 2 Small-Cap Bio-Pharmaceutical Companies: Discovery Labs And Exelexis
8/1/2014 9:22:00 PM - Seeking Alpha